30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Steven Bayern for Bayern Capital LLC

Insider profile

Steven Bayern for Bayern Capital LLC's trades of RetinalGenix Technologies Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-10 2026-06-11 PrS Proposed sale
49,742
245.88
US$4,640,765
49,742 245.88 US$4,640,765
2026-02-25 2026-02-26 PrS Proposed sale
5,338
251.30
US$4,421,811
5,338 251.30 US$4,421,811
2025-11-07 2025-11-10 PrS Proposed sale
64,227
401.43
US$4,857,377
64,227 401.43 US$4,857,377
2025-08-12 2025-08-13 PrS Proposed sale
100,000
3.54
US$354,000
100,000 3.54 US$354,000
2025-05-19 2025-05-12 PrS Proposed sale
100,000
3.52
US$352,000
100,000 3.52 US$352,000
2024-02-05 2024-02-05 PrS Proposed sale
9,700
3.16
US$30,700
9,700 3.16 US$30,700
2023-11-07 2023-11-07 PrS Proposed sale
10,000
4.49
US$44,900
10,000 4.49 US$44,900
2023-08-31 2023-08-31 PrS Proposed sale
10,000
9.40
US$94,000
10,000 9.40 US$94,000